Myovant Sciences Ltd.
- Pharmaceutical Preparations
- London, United Kingdom
Compensation history
Top executives at Myovant Sciences Ltd. received an average of $4M per person in annual compensation from 2015 to 2021.
By year
Executives
We found nine executives who work or worked at Myovant Sciences Ltd..
David Marek
Myovant Sciences Ltd.
Principal Executive Officer
Uneek Mehra
Myovant Sciences Ltd.
Principal Financial Officer
Frank Karbe
Myovant Sciences Ltd.
Former Principal Financial and Accounting Officer
Lauren Merendino
Myovant Sciences Ltd.
Chief Commercial Officer
Lynn Seely
Myovant Sciences Ltd.
Principal Executive Officer
Matthew Lang
Myovant Sciences Ltd.
General Counsel
Juan Ferreira
Myovant Sciences Ltd.
Chief Medical Officer
Kim Sablich
Myovant Sciences Ltd.
Chief Commercial Officer
News
Myovant Sciences Ltd. Principal Executive Officer David Marek's 2021 pay jumps 154% to $6.2M
July 27, 2022
Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2019 pay jumps 40% to $6.2M
July 24, 2020
Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2018 pay falls 64% to $4.4M
July 25, 2019
About Myovant Sciences Ltd.
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- Suite 1, 3rd Floor, 11-12 St. James Square, London, United Kingdom SW1Y 4LB
- 44 207-400-3351
- March 31